Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide corresponding to amino acids 32-45 of human TERE1.|
|Storage buffer||PBS, pH 7.4|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Western Blot (WB)||1-5 ug/ml|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
PA1-10887 detects TERE1 in human samples. Both mouse and rat TERE1 proteins are 85% homologous to the human TERE1 protein.
PA1-10887 has been successfully used in Western blot procedures, where a band of approximately 37 kDa is detected.
PA1-10887 immunogen is a synthetic peptide corresponding to amino acids 32-45 of human TERE1.
A ubiquitously expressed gene designated TERE1 (Transitional Epithelial Response Gene 1), which maps to chromosome 1p36.11-1p36.33, has a significant effect on growth regulation of bladder cancer and may play an equally significant role in growth regulation of prostate cancer. The TERE1 gene is located between the micro-satellite markers D1S2667 and D1S434, a chromosome locus that has been identified as a site of a tumor suppressor gene or genes for multiple tumor types. Induced TERE1 expression in two prostate carcinoma cell lines, LNCaP and PC-3, decreased proliferation up to 80% with a significant increase in the number of cells in G1. The TERE1 transcript is present in most normal human tissues, but is reduced or absent in the majority of muscle invasive TCC (Transitional Cell Carcinoma of the bladder) tumors.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
RP4-796F18.1; SCCD; TERE1; transitional epithelia response protein; Transitional epithelial response protein 1; UbiA prenyltransferase domain-containing protein 1
SCCD; TERE1; UBIAD1